Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesChange in TaxesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowNet Cash FlowNet IncomeShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Exozymes (EXOZ) Gains from Investment Securities (2023 - 2024)

Exozymes (EXOZ) has disclosed Gains from Investment Securities for 2 consecutive years, with $1.8 million as the latest value for Q3 2024.

  • Quarterly Gains from Investment Securities rose 3275.02% to $1.8 million in Q3 2024 from the year-ago period, while the trailing twelve-month figure was $1.8 million through Sep 2024, up 3275.02% year-over-year, with the annual reading at $1.0 million for FY2023, N/A changed from the prior year.
  • Gains from Investment Securities for Q3 2024 was $1.8 million at Exozymes, up from $1.0 million in the prior quarter.
  • The five-year high for Gains from Investment Securities was $1.8 million in Q3 2024, with the low at $51940.0 in Q3 2023.